Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02852837
Brief Title: Dose Escalation Study of JNJ-54767414 (Daratumumab) in Chinese Participants With Relapsed or Refractory Multiple Myeloma Who Failed at Least 2 Prior Lines of Systemic Therapy

First Submitted : July 29, 2016
First Submitted that Met QC Criteria : July 29, 2016
First Posted : August 2, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : December 5, 2019
Last Update Posted : December 6, 2019